Advertisement
Brief report| Volume 113, P33-37, March 2016

Endothelin-1 as a predictor of impaired glucose tolerance and type 2 diabetes – A longitudinal study in the Vara-Skövde Cohort

  • Author Footnotes
    1 These authors are contributed equally to this study.
    Josefin Olausson
    Footnotes
    1 These authors are contributed equally to this study.
    Affiliations
    The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Author Footnotes
    1 These authors are contributed equally to this study.
    Bledar Daka
    Footnotes
    1 These authors are contributed equally to this study.
    Affiliations
    Institute of Medicine, Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Margareta I. Hellgren
    Affiliations
    Institute of Medicine, Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Charlotte A. Larsson
    Affiliations
    Institute of Medicine, Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Social Medicine and Global Health, Department of Clinical Sciences, Malmö, Lund University, Sweden
    Search for articles by this author
  • Max Petzold
    Affiliations
    Institute of Medicine, Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Ulf Lindblad
    Affiliations
    Institute of Medicine, Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Per-Anders Jansson
    Correspondence
    Corresponding author at: Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Bruna Stråket 16, S-413 45 Gothenburg, Sweden. Tel.: +46 031 342 73 26.
    Affiliations
    The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Search for articles by this author
  • Author Footnotes
    1 These authors are contributed equally to this study.
Published:January 30, 2016DOI:https://doi.org/10.1016/j.diabres.2016.01.027
Endothelin-1 as a predictor of impaired glucose tolerance and type 2 diabetes – A longitudinal study in the Vara-Skövde Cohort
Previous ArticleComparison of the clinical characteristics of diabetes mellitus diagnosed using fasting plasma glucose and haemoglobin A1c: The 2011 Korea National Health and Nutrition Examination Survey
Next ArticleEffect of duodenal glucose load on blood pressure in type 2 diabetes

      Highlights

      • •
        Endothelin-1 may predict impaired glucose tolerance and type 2 diabetes in women.
      • •
        Endothelin-1 and impaired glucose metabolism (IGM) was not associated in men.
      • •
        Endothelin-1 exhibits apparent sex differences as a predictor of IGM.

      Abstract

      We addressed whether endothelin-1, a marker of endothelial dysfunction, predicts impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) in a population study in south-western Sweden. Follow-up after 9.7 years showed an association between circulating endothelin-1 levels at baseline and development of IGT/T2DM in women but not in men.

      Abbreviations:

      T2DM (type 2 diabetes mellitus), IGT (impaired glucose tolerance)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Caballero A.E.
        • Arora S.
        • Saouaf R.
        • Lim S.C.
        • Smakowski P.
        • Park J.Y.
        • et al.
        Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
        Diabetes. 1999; 48: 1856-1862
        View in Article
        • Shemyakin A.
        • Salehzadeh F.
        • Esteves Duque-Guimaraes D.
        • Bohm F.
        • Rullman E.
        • Gustafsson T.
        • et al.
        Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro.
        Diabetes. 2011; 60: 2061-2067
        View in Article
        • Ferri C.
        • Bellini C.
        • Desideri G.
        • Baldoncini R.
        • Properzi G.
        • Santucci A.
        • et al.
        Circulating endothelin-1 levels in obese patients with the metabolic syndrome.
        Exp Clin Endocrinol Diabetes. 1997; 105: 38-40
        View in Article
        • Ferri C.
        • Carlomagno A.
        • Coassin S.
        • Baldoncini R.
        • Cassone Faldetta M.R.
        • Laurenti O.
        • et al.
        Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
        Diabetes Care. 1995; 18: 226-233
        View in Article
        • Takahashi K.
        • Ghatei M.A.
        • Lam H.C.
        • O’Halloran D.J.
        • Bloom S.R.
        Elevated plasma endothelin in patients with diabetes mellitus.
        Diabetologia. 1990; 33: 306-310
        View in Article
        • Larsson C.A.
        • Daka B.
        • Gullberg B.
        • Rastam L.
        • Lindblad U.
        Clusters of AMI risk factors and their association with left ventricular hypertrophy: a population-based study within the Skaraborg Project, Sweden.
        Int J Cardiol. 2013; 168: 5416-5421
        View in Article
        • Hellgren M.I.
        • Daka B.
        • Jansson P.A.
        • Lindblad U.
        • Larsson C.A.
        Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity.
        Eur J Prev Cardiol. 2014; 22
        View in Article
        • Alberti K.G.
        • Zimmet P.Z.
        Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
        Diabet Med. 1998; 15: 539-553
        View in Article
        • Meigs J.B.
        • Hu F.B.
        • Rifai N.
        • Manson J.E.
        Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
        J Am Med Assoc. 2004; 291: 1978-1986
        View in Article
        • Polderman K.H.
        • Stehouwer C.D.
        • van Kamp G.J.
        • Dekker G.A.
        • Verheugt F.W.
        • Gooren L.J.
        Influence of sex hormones on plasma endothelin levels.
        Ann Intern Med. 1993; 118: 429-432
        View in Article

      Article info

      Publication history

      Published online: January 30, 2016
      Accepted: January 22, 2016
      Received in revised form: January 19, 2016
      Received: November 3, 2015

      Identification

      DOI: https://doi.org/10.1016/j.diabres.2016.01.027

      Copyright

      © 2016 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX